DIVISLABPharmaceuticals
Divis Laboratories Ltd — Balance Sheet
₹5947.00
-1.42%
Divis Laboratories Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Common Stock | 53.00 Cr | 53.00 Cr | 53.00 Cr | 53.09 Cr | — |
| Total Liabilities Net Minority Interest | 1.96K Cr | 1.90K Cr | 1.67K Cr | 1.65K Cr | — |
| Total Non Current Liabilities Net Minority Interest | 511.00 Cr | 621.00 Cr | 571.00 Cr | 450.98 Cr | — |
| Non Current Pension And Other Postretirement Benefit Plans | 0.00 | 37.00 Cr | 31.00 Cr | 26.71 Cr | — |
| Non Current Deferred Taxes Liabilities | 509.00 Cr | 582.00 Cr | 537.00 Cr | 421.40 Cr | — |
| Long Term Debt And Capital Lease Obligation | 2.00 Cr | 2.00 Cr | 3.00 Cr | 2.87 Cr | — |
| Long Term Capital Lease Obligation | 2.00 Cr | 2.00 Cr | 3.00 Cr | 2.87 Cr | — |
| Current Liabilities | 1.45K Cr | 1.28K Cr | 1.10K Cr | 1.20K Cr | — |
| Other Current Liabilities | 19.00 Cr | 31.00 Cr | 9.00 Cr | -10.24 Cr | — |
| Current Debt And Capital Lease Obligation | 2.00 Cr | 1.00 Cr | 1.00 Cr | 0.82 Cr | — |
| Current Capital Lease Obligation | 0.00 | 1.00 Cr | 1.00 Cr | 0.82 Cr | — |
| Current Debt | 2.00 Cr | 0.00 | 0.00 | 0.00 | — |
| Pensionand Other Post Retirement Benefit Plans Current | 54.00 Cr | 7.00 Cr | 5.00 Cr | 4.15 Cr | — |
| Current Provisions | 54.00 Cr | 7.00 Cr | 4.92 Cr | 4.15 Cr | — |
| Payables | 1.34K Cr | 1.20K Cr | 1.04K Cr | 1.17K Cr | — |
| Other Payable | 425.00 Cr | 336.00 Cr | 282.00 Cr | 368.35 Cr | — |
| Dividends Payable | 1.00 Cr | 1.00 Cr | 1.00 Cr | 1.07 Cr | — |
| Total Tax Payable | 0.00 | 43.00 Cr | -6.00 Cr | 1.68 Cr | — |
| Accounts Payable | 910.00 Cr | 824.00 Cr | 762.00 Cr | 795.70 Cr | — |
| Total Assets | 16.93K Cr | 15.47K Cr | 14.44K Cr | 13.37K Cr | — |
| Total Non Current Assets | 6.85K Cr | 5.79K Cr | 5.13K Cr | 5.02K Cr | — |
| Other Non Current Assets | 248.00 Cr | 129.00 Cr | 21.00 Cr | 54.83 Cr | — |
| Non Current Prepaid Assets | 72.00 Cr | 58.00 Cr | 79.00 Cr | 86.27 Cr | — |
| Non Current Deferred Taxes Assets | 11.00 Cr | 10.00 Cr | 14.00 Cr | 14.47 Cr | — |
| Investmentin Financial Assets | 65.00 Cr | 82.00 Cr | 77.00 Cr | 72.01 Cr | — |
| Available For Sale Securities | 127.00 Cr | 138.00 Cr | 128.14 Cr | 129.76 Cr | — |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | 65.00 Cr | 82.00 Cr | 77.00 Cr | 72.01 Cr | — |
| Goodwill And Other Intangible Assets | 4.00 Cr | 4.00 Cr | 5.00 Cr | 7.49 Cr | — |
| Other Intangible Assets | 4.00 Cr | 4.00 Cr | 5.00 Cr | 7.49 Cr | — |
| Net PPE | 6.70K Cr | 5.63K Cr | 4.95K Cr | 4.84K Cr | — |
| Accumulated Depreciation | -2.40K Cr | -2.00K Cr | -1.62K Cr | -1.28K Cr | — |
| Gross PPE | 9.10K Cr | 7.63K Cr | 6.57K Cr | 6.12K Cr | — |
| Construction In Progress | 1.26K Cr | 897.00 Cr | 231.00 Cr | 518.25 Cr | — |
| Other Properties | 319.00 Cr | 262.00 Cr | 244.00 Cr | 217.18 Cr | — |
| Machinery Furniture Equipment | 5.19K Cr | 4.61K Cr | 4.33K Cr | 3.77K Cr | — |
| Buildings And Improvements | 6.00 Cr | 6.00 Cr | 6.00 Cr | 5.30 Cr | — |
| Land And Improvements | 2.33K Cr | 1.86K Cr | 1.75K Cr | 1.61K Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 10.08K Cr | 9.68K Cr | 9.31K Cr | 8.35K Cr | — |
| Other Current Assets | 370.00 Cr | 320.00 Cr | 201.77 Cr | 0.05 Cr | — |
| Restricted Cash | 188.00 Cr | 282.00 Cr | 81.00 Cr | 77.22 Cr | — |
| Prepaid Assets | 140.00 Cr | 147.00 Cr | 161.00 Cr | 117.87 Cr | — |
| Inventory | 3.24K Cr | 3.18K Cr | 3.00K Cr | 2.83K Cr | — |
| Other Inventories | 9.00 Cr | 8.00 Cr | 9.00 Cr | — | 8.38 Cr |
| Finished Goods | 335.00 Cr | 317.00 Cr | 302.00 Cr | 319.15 Cr | — |
| Work In Process | 1.70K Cr | 1.62K Cr | 1.53K Cr | 1.53K Cr | — |
| Raw Materials | 1.19K Cr | 1.24K Cr | 1.16K Cr | 977.88 Cr | — |
| Other Receivables | 2.00 Cr | 2.00 Cr | 2.00 Cr | 2.60 Cr | — |
| Taxes Receivable | 245.00 Cr | 203.00 Cr | 139.00 Cr | 159.54 Cr | — |
| Accounts Receivable | 2.73K Cr | 2.16K Cr | 1.79K Cr | 2.42K Cr | — |
| Allowance For Doubtful Accounts Receivable | -7.00 Cr | -10.00 Cr | -6.00 Cr | -5.12 Cr | — |
| Gross Accounts Receivable | 2.74K Cr | 2.17K Cr | 1.80K Cr | 2.43K Cr | — |
| Cash Cash Equivalents And Short Term Investments | 3.54K Cr | 3.70K Cr | 4.14K Cr | 2.74K Cr | — |
| Other Short Term Investments | 3.12K Cr | 3.34K Cr | 3.97K Cr | 1.53K Cr | — |
| Cash And Cash Equivalents | 415.00 Cr | 363.00 Cr | 170.00 Cr | 1.21K Cr | — |
| Cash Equivalents | 394.00 Cr | 340.00 Cr | 141.00 Cr | 1.19K Cr | — |
| Cash Financial | 21.00 Cr | 23.00 Cr | 29.00 Cr | 21.88 Cr | — |
| Ordinary Shares Number | 26.55 Cr | 26.55 Cr | 26.55 Cr | 26.55 Cr | — |
| Share Issued | 26.55 Cr | 26.55 Cr | 26.55 Cr | 26.55 Cr | — |
| Total Debt | 4.00 Cr | 3.00 Cr | 4.00 Cr | 3.69 Cr | — |
| Tangible Book Value | 14.96K Cr | 13.57K Cr | 12.76K Cr | 11.72K Cr | — |
| Invested Capital | 14.97K Cr | 13.57K Cr | 12.77K Cr | 11.73K Cr | — |
| Working Capital | 8.63K Cr | 8.40K Cr | 8.21K Cr | 7.16K Cr | — |
| Net Tangible Assets | 14.96K Cr | 13.57K Cr | 12.76K Cr | 11.72K Cr | — |
| Capital Lease Obligations | 2.00 Cr | 3.00 Cr | 4.00 Cr | 3.69 Cr | — |
| Common Stock Equity | 14.97K Cr | 13.57K Cr | 12.77K Cr | 11.73K Cr | — |
| Total Capitalization | 14.97K Cr | 13.57K Cr | 12.77K Cr | 11.73K Cr | — |
| Total Equity Gross Minority Interest | 14.97K Cr | 13.57K Cr | 12.77K Cr | 11.73K Cr | — |
| Stockholders Equity | 14.97K Cr | 13.57K Cr | 12.77K Cr | 11.73K Cr | — |
| Other Equity Interest | 14.92K Cr | 13.52K Cr | 12.71K Cr | 11.68K Cr | — |
| Retained Earnings | 13.40K Cr | 11.79K Cr | 10.96K Cr | 9.99K Cr | — |
| Additional Paid In Capital | 80.00 Cr | 80.00 Cr | 80.00 Cr | 79.88 Cr | — |
| Capital Stock | 53.00 Cr | 53.00 Cr | 53.00 Cr | 53.09 Cr | — |
| Long Term Provisions | — | 37.00 Cr | 30.62 Cr | 26.71 Cr | 25.25 Cr |
| Current Deferred Taxes Liabilities | — | 43.00 Cr | 2.00 Cr | 6.80 Cr | 8.34 Cr |
| Treasury Shares Number | — | 0.00 | — | — | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Divis Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.